ロード中...

Effect of Alzheimer disease genetic risk disclosure on dietary supplement use(1)(2)(3)(4)

Background: Genetic susceptibility testing for Alzheimer disease (AD) with APOE genotype disclosure is not recommended for clinical use but is available through direct-to-consumer (DTC) genetic testing companies. Little is known about whether APOE genotype disclosure would actually prompt changes in...

詳細記述

保存先:
書誌詳細
主要な著者: Vernarelli, Jacqueline A, Roberts, J Scott, Hiraki, Susan, Chen, Clara A, Cupples, L Adrienne, Green, Robert C
フォーマット: Artigo
言語:Inglês
出版事項: American Society for Nutrition 2010
主題:
オンライン・アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC2854909/
https://ncbi.nlm.nih.gov/pubmed/20219963
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3945/ajcn.2009.28981
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!